Mottola Frank (CIK 1804567) reported 33 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-10). Recent activity: Buy SUPN (3,750 shares), Sell SUPN (1,793 shares), Sell SUPN (1,623 shares), Buy SUPN (1,875 shares), Sell SUPN (977 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Buy | 3,750 | $0 |
| 2026-03-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Sell | 1,793 | $98,131 |
| 2026-03-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Sell | 1,623 | $87,074 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Buy | 1,875 | $0 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Sell | 977 | $49,524 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Buy | 1,125 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Sell | 603 | $30,964 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Buy | 750 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Sell | 368 | $18,716 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Buy | 1,250 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Sell | 670 | $34,076 |
| 2025-12-22 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Sell | 5,000 | $251,100 |
| 2025-12-22 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Buy | 5,000 | $197,000 |
| 2025-12-22 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Buy | 15,000 | $379,500 |
| 2025-12-22 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Sell | 15,000 | $757,050 |
| 2025-09-15 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Buy | 5,000 | $197,000 |
| 2025-09-15 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Tech. Ops. Officer | Sell | 5,000 | $229,350 |
| 2025-08-27 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Quality, GMP, Ops, IT | Buy | 14,000 | $181,720 |
| 2025-08-27 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Quality, GMP, Ops, IT | Sell | 14,000 | $623,140 |
| 2025-03-07 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Quality, GMP, Ops, IT | Buy | 2,625 | $0 |
| 2025-03-07 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Quality, GMP, Ops, IT | Sell | 1,356 | $53,033 |
| 2025-03-05 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Quality, GMP, Ops, IT | Sell | 337 | $11,138 |
| 2025-03-05 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Quality, GMP, Ops, IT | Sell | 610 | $20,160 |
| 2025-03-05 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Quality, GMP, Ops, IT | Sell | 945 | $31,232 |
| 2025-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Quality, GMP, Ops, IT | Buy | 2,010 | $0 |
Source: SEC Form 4 filings · as of 2026-03-10